Tabituximab barzuxetan

Tax included
Tabituximab barzuxetan (OTSA101-DTPA-90Y) is a radioimmunoconjugate composed of a humanized monoclonal antibody targeting FZD-10 (OTSA-101), and labeled with Yttrium 90. Tabituximab barzuxetan shows antineoplastic activity. Tabituximab barzuxetan can be used for synovial sarcoma research.
MedChemExpress 
HY-P99581

Data sheet

Size
Multiple sizes
Reactivity
Wnt
CAS
1612758-88-9